Trials / Completed
CompletedNCT00673725
Locobase® REPAIR Used as an Adjunctive to Standard Therapy in Children With Moderate to Severe Atopic Dermatitis
A Phase IV,Open Label Study of the Treatment of Children With Moderate to Severe Atopic Dermatitis (AD) Using Locobase® REPAIR as an Adjunctive to Standard Treatment
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 49 (actual)
- Sponsor
- Astellas Pharma Europe B.V. · Industry
- Sex
- All
- Age
- 18 Months – 16 Years
- Healthy volunteers
- Not accepted
Summary
To assess the efficacy of Locobase REPAIR® when used in children with moderate to severe AD
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Locobase® REPAIR | emollient |
Timeline
- Start date
- 2008-03-01
- Primary completion
- 2008-09-01
- Completion
- 2008-09-01
- First posted
- 2008-05-07
- Last updated
- 2014-08-25
Locations
3 sites across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT00673725. Inclusion in this directory is not an endorsement.